These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4714591)

  • 1. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.
    Andén NE; Atack CV; Svensson TH
    J Neural Transm; 1973; 34(2):93-100. PubMed ID: 4722575
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Hamberger B; Malmfors T; Sachs C
    Eur J Pharmacol; 1969 Oct; 8(1):58-72. PubMed ID: 5357075
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation by reserpine of the inhibition by amphetamine of (3H)dopamine accumulation in the rat striatum.
    Ross SB
    J Pharm Pharmacol; 1977 Jul; 29(7):433-4. PubMed ID: 19583
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 9. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of bradykinin with dopaminergic receptors in the CNS.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1977; 29(3):301-11. PubMed ID: 887505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of d-amphetamine on spontaneous and stimulation-induced release of catecholamines.
    Farnebo LO
    Acta Physiol Scand Suppl; 1971; 371():45-52. PubMed ID: 4112832
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
    Farnebo LO; Fuxe K; Goldstein M; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1971 Sep; 16(1):27-38. PubMed ID: 5157529
    [No Abstract]   [Full Text] [Related]  

  • 17. Amphetamine induced stereotyped behaviour correlated with the accumulation of O-methylated dopamine.
    Jonas W; Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):379-89. PubMed ID: 5807174
    [No Abstract]   [Full Text] [Related]  

  • 18. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Azzaro AJ; Rutledge CO
    Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.